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Abstract Pelvic surgery can affect ovarian reserve, but esti-
mates of the potential effect of different surgical procedures
are lacking. This study examines the markers of ovarian re-
serve after different procedures in order to help the provision
of informed consent before surgery. Anti-Müllerian hormone
(AMH), antral follicle count (AFC) and follicle-stimulating
hormone (FSH) of women with a history of salpingectomy,
ovarian cystectomy or unilateral salpingo-oophorectomy were
compared to those without history of surgery using cross-
sectional data adjusting for patient and clinical factors in mul-
tivariable regression model. There were 138 women who had
had salpingectomy, 36 unilateral salpingo-oopherectomy, 41
cystectomy for ovarian cysts that are other than endometrioma
and 40 women had had excision of endometrioma. There was
no significant difference in AMH (9%; p = 0.33), AFC (−2%;
p = 0.59) or FSH (−14%; p = 0.21) in womenwith a history of
salpingectomy compared to women without surgery. Women
with a history of unilateral salpingo-oophorectomy were
found to have significantly lower AMH (−54 %; p = 0.001).
These women also had lower AFC (−28 %; p = 0.34) and
higher FSH (14 %; p = 0.06), the effect of which did not reach
statistical significance. The study did not find any significant
associations between a history of cystectomy, for disease other
than endometrioma and AMH (7 %; p = 0.62), AFC (13 %;
p = 0.18) or FSH. (11 %; p = 0.16). Women with a history of
cystectomy for ovarian endometrioma had 66 % lower AMH
(p = 0.002). Surgery for endometrioma did not significantly
affect AFC (14 %; p = 0.22) or FSH (10 %; p = 0.28).
Salpingo-oopherectomy and cystectomy for endometrioma
cause a significant reduction in AMH levels. Neither
salpingectomy nor cystectomy for cysts other than
endometrioma has appreciable effects on ovarian reserve.
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Introduction
Human ovarian reserve is determined by the size of oocyte
pool at birth and an age-related decline in oocyte numbers
thereafter. Both of these processes are largely under the influ-
ence of genetic factors, and to date, no effective interventions
are available to improve physiological ovarian reserve [1].
However, various other environmental, pathological and iat-
rogenic factors appear to play a role, and consequently, it may
be influenced either directly or indirectly. The use of chemo-
therapeutic agents, certain radio-therapeutic modalities and
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surgical interventions that damage the ovarian parenchyma
can cause substantial damage to ovarian reserve [2, 3].
Estimation of the effect of each of these interventions is of
importance in identifying lesser ootoxic treatment modalities.
Age is the main determinant of the number of non-growing
follicles, accounting for 84 % of its variation. [4]. However,
biomarkers that allow direct assessment of dynamics of grow-
ing follicles, anti-Müllerian hormone (AMH) and antral folli-
cle count (AFC) may provide more accurate estimation of
ovarian reserve [5]. Although these markers only reflect
folliculogenesis of already recruited growing follicles, there
appears to be a good correlation between their measurements
and histologically determined total ovarian reserve [4]. Thus,
the biomarkers can be utilised for the estimation of the effect
of the above adverse factors on the primordial oocyte pool.
Surgical interventions that lead to disruption of the blood
supply to the ovaries or involve direct damage to ovarian
tissue may be expected to lead to a reduction in the primordial
follicle pool. Indeed, a number of studies have reported an
association between surgical interventions to the ovaries and
a reduction in ovarian reserve [3]. However, given that both
the underlying disease and surgery may affect ovarian reserve,
disentanglement of the individual effects of these factors may
be challenging and requires careful analysis. Here, we present
a study that, in as far as is possible in cross-sectional data,
intended to estimate the effect of tubal and ovarian surgery
on ovarian reserve independently of underlying disease.
Methods
The effect of salpingectomy, ovarian cystectomy and unilater-
al salpingo-oopherectomy on ovarian reserve was studied
using serum biomarkers AMH, AFC and follicle-stimulating
hormone (FSH) in a large cross-sectional study of patients
referred for infertility management.
Population
All women between ages of 20 to 45 who were referred to the
Women’s Outpatient Department and the Reproductive
Medicine Department of Central Manchester University
Hospitals NHS Foundation Trust for management of infertility
between 1 September 2008 and 16 November 2010 and had
AMH measurement using the DSL assay ((DSL, Active MIS/
AMH ELISA; Diagnostic Systems Laboratories, Webster,
TX) were included. We excluded patients referred for fertility
preservation and those with a diagnosis of polycystic ovaries
(PCO) on transvaginal ultrasound scan which was defined as
volume of one or both ovaries more than 10 ml. Patients with
haemolysed AMH and/or FSH samples were not included in
the analysis of these markers.
Measurement of AMH
Blood samples for AMHwere taken without regard to the day
of women’s menstrual cycle. Serum samples were separated
within 2 h of venipuncture in the Biochemistry Laboratory of
our hospital and frozen at −20 °C until analysed in batches
using the enzymatically amplified two-site immunoassay
(DSL, Active MIS/AMH ELISA; Diagnostic Systems
Laboratories, Webster, TX). All samples were processed
strictly according to the manufacturer’s recommendations.
The working range of the assay was up to 100 pmol/L and a
minimum detection limit was 0.63 pmol/L. The intra-assay
coefficient of variation (CV) (n = 16) was 3.9 % (at
10 pmol/l) and 2.9 % (at 56 pmol/l). The inter-assay CV
(n = 60) was 4.7 % (at 10 pmol/l) and 4.9 % (at 56 pmol/l).
Measurement of FSH
Women had measurement of basal FSH, luteinizing hormone
(LH) and oestradiol levels (E2) during early follicular phase
(days 2–5) of their menstrual cycle as part of their initial
workup. Blood samples were transported to the
Biochemistry Laboratory within 2 h of venipuncture for sam-
ple processing and analysis. Specific immunoassay kits
(Cobas, Roche Diagnostics, Mannheim, Germany) and an
autoanalyser platform were used (Roche Modular Analytics
E170, Roche, USA) for analysis of FSH. The intra-assay CV
was 6.0 % and inter-assay CV was 6.8 %.
Measurement of AFC
Measurement of AFC was conducted in patients referred for
assisted conception. The department used a stringent method-
ology for the assessment of AFC, which consists of counting
all antral follicles measuring 2–6 mm in longitudinal and
transverse cross sections of both ovaries using transvaginal
ultrasound scanning (Toshiba Nemio F2534312) at early fol-
licular phase of the menstrual cycle. The AFC with the closest
date to AMH measurement was selected. The ultrasound as-
sessments were conducted by a number of qualified
sonographers, who used the same methodology for the mea-
surement of AFC.
Definitions and groups
Women’s body mass index (BMI) was categorised using stan-
dard NHS reference ranges: Underweight (<18.5), Normal
(18.5–24.9), Overweight (25–29.9) and Obese (30–40) [8]).
The causes of infertility were established by searching the
referral letters, clinical notes and letters generated following
clinic consultations. Women with a history of bilateral tubal
block, which was confirmed by laparoscopic dye test, and
patients with a history of bilateral salpingectomy were
174 Gynecol Surg (2016) 13:173–178
categorised as having severe tubal factor infertility. Women
with unilateral tubal patency or unilateral salpingectomy were
categorised as having mild tubal factor infertility. Severe male
factor infertility was defined as azoospermia or severe
oligospermia (<1 mln sperm sample) and partners with abnor-
mal sperm count that do not meet the above criteria being
classified as having mild male factor infertility.
Patients with reproductive surgery were categorised as hav-
ing a history of salpingectomy, unilateral salpingo-
oopherectomy, cystectomy for ovarian cysts other than ovar-
ian endometrioma and cystectomy for endometrioma. In our
department, stripping of cyst wall with subsequent diathermy
of bleeding areas of the cyst bed is the standard method for
excision of endometriotic cyst. However, the dataset did not
contain data on surgical techniques and, therefore, we were
not able to investigate the effect of specific surgical
procedures.
Statistical analysis
A multivariable regression model that included age, ethnicity,
endometriosis, presence of ovarian endometrioma, causes of
infertility, and tubal and ovarian surgery was fitted to the log-
arithm of each of the ovarian reserve markers: AMH, AFC
and FSH. The age on the day of the measurement of each of
the marker of ovarian reserve (AMH, AFC and FSH) was
included in the model as a quadratic function following cen-
tering to 30 years of age. Preliminary analysis of AMH, AFC
and FSH indicated that logarithmically transformed values
with a quadratic age term provided adequate fits. Differences
between the groups were considered significant at p < 0.05.
Interactions between all explanatory variables were tested at a
significance level of 0.01.
Results
In total, 3179 women were included in the study. The AMH
measurements of 66 women were excluded due to
haemolysed samples or delay in processing the samples, leav-
ing 3113 women for analysis. Of women, 1934 had AFC and
2580 had FSH. The mean (±SD) age, AMH, AFC and FSH of
patients were 32.8 ± 4.5, 17.3 ± 14.8, 13.9 ± 6.2 and 8.0 ± 7.5,
respectively. There were 138 women who had unilateral or
bilateral salpingectomy, 36 women with a history of unilateral
salpingo-oopherectomy, 41 women with a history of
cystectomy for ovarian cysts other than endometrioma and
40 women had cystectomy for endometrioma. The results of
the regression analysis on the effect of reproductive surgery on
AMH, AFC and FSH are shown in Table 1.
The analysis did not find any significant differences in AMH
(increase of 9 %; p = 0.33), AFC (−2 %; p = 0.59) and FSH
(−14 %; p = 0.21) between women with a history of
salpingectomy and those without surgery (Table 1).Womenwith
a history of unilateral salpingo-oopherectomy were found to
have significantly lower AMH (−54 %; p = 0.001) and AFC
(−28 %; p = 0.34) and increased FSH (14 %; p = 0.06), and
the effect on AMH reached statistical significance (Table 1). The
study did not find a significant association between previous
history of ovarian cystectomy that was for disease other than
endometrioma and AMH (7 %; p = 0.62), AFC (13 %;
p = 0.18) or FSH (11 %; p = 0.16) (Table 1). Women with a
history of ovarian cystectomy for endometrioma had 66% lower
AMH (p = 0.002) levels but the effects on AFC (14%; p = 0.22)
and FSH (10 %; p = 0.28) were not significant (Table 1).
Discussion
In salpingectomy, tubal and ovarian branches of uterine arter-
ies are often excised alongside the mesosalpynx and, hence, it
is believed that disruption to blood supply to ovaries may lead
to reduction of ovarian reserve. However, in our study, we did
not observe an appreciable associat ion between
salpingectomy and any of the biomarkers of ovarian reserve
suggesting this surgery does not affect ovarian reserve. These
findings are supported by a longitudinal study that assessed
the effect of tubal dissection to AMH, AFC and FSH (n = 49)
[6]. There were no differences between preoperative and 3-
month postoperative measurements with median AMH (1.5
Table 1 Multivariable regression analysis
Number Coef 95 % CI p
Salpingectomy
AMH 2128 0.094 −0.097, 0.285 0.333
AFC 1697 −0.027 −0.126, 0.072 0.595
FSH 1929 −0.056 −0.143, 0.032 0.210
Oopherectomy
AMH 3049 −0.540 −0.868, −0.213 0.001
AFC 1946 −0.280 −0.857, 0.298 0.342
FSH 2546 0.139 −0.006, 0.284 0.060
Cystectomy other
AMH 2128 0.075 −0.226, 0.376 0.626
AFC 1697 0.130 −0.064, 0.323 0.189
FSH 1929 0.110 −0.044, 0.265 0.161
Cystectomy endometrioma
AMH 2128 −0.667 −1.081, −0.252 0.002
AFC 1697 0.144 −0.089, 0.376 0.225
FSH 1929 0.103 −0.084, 0.290 0.281
The fitted coefficient (log difference between the group indicated and all
other patients), 95 % confidence interval and associated p value adjusted
for age, ethnicity causes of infertility, endometriosis (without
endometrioma) and endometrioma
Statistically significant values (p<0.005) are provided in bold
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vs. 1.4; p = 0.07), AFC (8.4 ± 3.7 vs. 7.9 ± 4.1; p = 0.09), FSH
(7.6 ± 2.1 vs. 7.7 ± 2.1; p = 0.10). Silva et al. assessed the
effect of tubal ligation (n = 52) in longer term postoperative
period (1 year) and reported that median AMH (1.43, IQR
0.63–2.62 vs. 1.30, IQR 0.53–2.85; p = 0.23) and mean
AFC (8, IQR 5–14 vs. 11, IQR 7–15; p = 0.12) did not change
significantly [7]. Thus, our results along with other published
evidence suggest that salpingectomy or tubal division does not
have an adverse effect on ovarian reserve. Therefore, advising
salpingectomy for various indications, including treatment of
tubal pathology, sterilisation or opportunistic procedure as part
of risk reduction strategy in ovarian carcinoma appears to be
safe with regard to preserving ovarian reserve.
Although salpingo-oopherectomy is rare in women of re-
productive age, significant ovarian pathologies and acute dis-
eases such as ovarian torsion may necessitate unilateral
salpingo-oopherectomy. There is plausible causative relation-
ship between this surgery and ovarian reserve, although to our
knowledge there is no previous published evidence.We found
that women with history of unilateral salpingo-oopherectomy
have significantly lowerAMH (−54%) suggesting the surgery
has considerable negative impact on ovarian reserve measured
with this biomarker. Similarly, the patients with a history of
salpingo-oopherectomy had considerably higher FSH (13 %)
and lower (−24 %) AFC. However, these did not reach statis-
tical significance which may be due to small sample size and
relative poor discriminatory power of AFC and FSH com-
pared to that of AMH. The important clinical question in the
management of patients with salpingo-oopherectomy is
whether these patients have comparable reproductive lifespan
or experience accelerated loss of oocytes resulting in prema-
ture loss of fertility, as this would allow appropriate preoper-
ative counseling of patients regarding the long-term effect of
the surgery on fertility and age at menopause. There is a need
for studies with a larger number of patients, preferably using
long-term longitudinal data, to investigate this question.
In women with a history of ovarian cystectomy for cysts
other than those due to endometrioma, we did not observe any
significant association between surgery and markers of ovar-
ian reserve. However, women that had ovarian cystectomy for
endometrioma appear to have significantly lower AMH
(−66 %) compared to those without a history of surgery.
During the last few years, a number of studies have
assessed the effect of excision of endometrioma on AMH
[8–10]. The studies have been summarised by a recent sys-
tematic review, which concluded that excision of
endometrioma results in damage to ovarian reserve [3].
Further studies evaluated the mechanism of damage, and these
suggest that coagulation for the purpose of hemostasis as well
as stripping of the cyst wall may cause direct damage to ovar-
ian reserve. Sonmezer et al. compared the effect of diathermy
coagulation (n = 15) for hemostasis compared to the use of
hemostatic matrix (n = 13) in a randomised controlled trial and
reported that the use of diathermy coagulation is associated
with significantly lower AMH measurements (1.64 ± 0.93 vs.
2.72 ± 1.49 ng/mL) in the first postoperative month [11].
Similarly, stripping of the cyst wall also appears to have a
detrimental effect on ovarian reserve due to inadvertent re-
moval of ovarian tissue [12]. Using histological data, Roman
et al. demonstrated that normal ovarian tissue was removed in
97 % specimens of surgically removed endometriomata [13].
Furthermore, it appears that ovarian cortex containing
endometrioma appears to have significantly reduced density
compared to normal ovarian cortex, and therefore, loss of
oocyte containing normal ovarian cortex may be unavoidable
in cystectomy for endometrioma [14]. Matsuzaki et al. con-
ducted a histological assessment of cystectomy specimens and
found that normal ovarian tissue adjacent to cyst wall was
found in 58 % (71/121) of patients with endometrioma,
whereas normal ovarian tissue was excised in 5.4 % (3/56)
following cystectomy for other benign cysts [15]. Donnez et
al. reported the use of combined stripping and vaporization
Fig. 1 AMH by treatment
groups. Left hand panel shows the
raw data AMH measurement (in
pmol/L) and the right hand panel
the AMH adjusted for age,
ethnicity, causes of infertility,
endometriosis, endometrioma and
surgery using the multivariable
regression model for the various
treatment groups
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technique was safe with regard to protecting an ovarian re-
serve [16]. More recently, Ata et al. reported that mean decline
of AMH levels was less in suturing and haemostatic sealent
technique compared to bipolar desiccation suggesting energy
sources may have more detrimental effect on ovarian reserve
[17].
Interestingly, contrary to AMH levels, the surgery does not
seem to affect AFCmeasurements. A recent systematic review
of 13 studies reported that AFC did not change following
excision of endometrioma compared to that of prior surgery
[18]. Similarly, our data did not show a significant difference
in AFC measurements in patients with a history of excision of
endometrioma, whilst AMH measurements of the patients
with surgery was significantly (66 %) lower. This suggests
that either (a) there is increased expression of AMH in the
presence of endometrioma and hence the dramatic decline
following cystectomy or (b) the performance characteristics
of AFC is not sufficiently precise for the detection of change
between the measurements. We believe exploration of these
questions further may improve our understanding of the path-
ophysiology of ovarian endometriosis and performance of the
markers of ovarian reserve in the presence of the disease.
In summary, in our study, women with a history of
cystectomy for endometrioma had significantly lower AMH,
whilst those had cystectomy for other benign cysts do not
appear to have lower AMH. In view of our findings and other
published research evidence, it seems clear that cystectomy
for endometrioma results in a significant reduction in AMH
levels.
Strengths and limitations
The published studies have used longitudinal data comparing
biomarkers before and after cystectomy and provide reliable
estimates on the effect of the intervention on ovarian reserve.
However, data on the effect of salpingectomy and unilateral
salpingo-oopherectomy is lacking. In addition to a reevalua-
tion of the effect of cystectomy, this study has assessed the
impact of salpingectomy and unilateral salpingo-
oopherectomy on markers of ovarian reserve. In contrast to
published studies, this study employed analysis of cross-
sectional data. Although we have adjusted for all the measured
confounders, we cannot be certain that all relevant factors
have been included and the apparent effects of surgery here
may be causally related to some unmeasured factor related to
the decision whether or not to intervene surgically. In patients
with a history of cystectomy for endometrioma, we estimated
independent effects of pathology and surgery providing im-
portant data for preoperative counseling.
It is important to note that the study evaluated the effect of
surgery using retrospective data which has limitations due
variation in recording of surgical history and missing data.
Recent studies showed that AMH measurements may be
prone to an inaccuracy due to methodological issues [19,
20]. However, this appears to be largely confined to initial
Gen II AMH Assay [20, 21]. The study employed the data
obtained using first-generation DSL AMH assay, which ap-
pears to provide more reproducible measurements [20, 22].
It is important to note although the effects are significant in
a population level, there is considerable variation between
individuals in the effects of surgery (Fig. 1). It is not clear
whether this variability represents measurement error arising
from the assays and sampling procedures, or true inter-
individual differences in the effects between women. Thus,
clinicians should exercise caution in predicting the effect of
surgery on the ovarian reserve of individual patients.
Conclusion
This multivariable regression analysis of retrospectively col-
lected cross-sectional data suggests that neither salpingectomy
nor ovarian cystectomy for cysts other than endometrioma has
an appreciable effect on ovarian reserve determined by AMH,
AFC and FSH. In contrast, salpingo-oopherectomy and ovar-
ian cystectomy for endometrioma appear to have a significant
detrimental impact on ovarian reserve. On the basis of find-
ings of this study and other published studies, women under-
going reproductive surgery should be counseled with regard to
the potential adverse effect of the surgery on their ovarian
reserve.
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